Stock INTI INHIBITOR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Inhibitor Therapeutics, Inc.

Equities

INTI

US45720M1053

Delayed OTC Markets
Other stock markets
 03:24:08 2024-07-08 pm EDT 		5-day change 1st Jan Change
0.085 USD +6.25% Intraday chart for Inhibitor Therapeutics, Inc. +7.59% -7.61%
May. 13 Inhibitor Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 29 Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
INHIBITOR THERAPEUTICS, INC. Stock Inhibitor Therapeutics, Inc.
 14.65M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 127B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 116B
ARGENX SE Stock argenx SE
 27.69B -
BIONTECH SE Stock BioNTech SE
 19.62B -
GENMAB A/S Stock Genmab A/S
 16.26B
  1. Stock Market
  2. Equities
  3. INTI Stock
  4. Charts Inhibitor Therapeutics, Inc.
  5. Sector Chart